» Articles » PMID: 21103067

Sox2 is Essential for Formation of Trophectoderm in the Preimplantation Embryo

Overview
Journal PLoS One
Date 2010 Nov 25
PMID 21103067
Citations 77
Authors
Affiliations
Soon will be listed here.
Abstract

Background: In preimplantation mammalian development the transcription factor Sox2 (SRY-related HMG-box gene 2) forms a complex with Oct4 and functions in maintenance of self-renewal of the pluripotent inner cell mass (ICM). Previously it was shown that Sox2-/- embryos die soon after implantation. However, maternal Sox2 transcripts may mask an earlier phenotype. We investigated whether Sox2 is involved in controlling cell fate decisions at an earlier stage.

Methods And Findings: We addressed the question of an earlier role for Sox2 using RNAi, which removes both maternal and embryonic Sox2 mRNA present during the preimplantation period. By depleting both maternal and embryonic Sox2 mRNA at the 2-cell stage and monitoring embryo development in vitro we show that, in the absence of Sox2, embryos arrest at the morula stage and fail to form trophectoderm (TE) or cavitate. Following knock-down of Sox2 via three different short interfering RNA (siRNA) constructs in 2-cell stage mouse embryos, we have shown that the majority of embryos (76%) arrest at the morula stage or slightly earlier and only 18.7-21% form blastocysts compared to 76.2-83% in control groups. In Sox2 siRNA-treated embryos expression of pluripotency associated markers Oct4 and Nanog remained unaffected, whereas TE associated markers Tead4, Yap, Cdx2, Eomes, Fgfr2, as well as Fgf4, were downregulated in the absence of Sox2. Apoptosis was also increased in Sox2 knock-down embryos. Rescue experiments using cell-permeant Sox2 protein resulted in increased blastocyst formation from 18.7% to 62.6% and restoration of Sox2, Oct4, Cdx2 and Yap protein levels in the rescued Sox2-siRNA blastocysts.

Conclusion And Significance: We conclude that the first essential function of Sox2 in the preimplantation mouse embryo is to facilitate establishment of the trophectoderm lineage. Our findings provide a novel insight into the first differentiation event within the preimplantation embryo, namely the segregation of the ICM and TE lineages.

Citing Articles

Divergent destinies: insights into the molecular mechanisms underlying EPI and PE fate determination.

Athanasouli P, Vanhessche T, Lluis F Life Sci Alliance. 2025; 8(3).

PMID: 39779220 PMC: 11711469. DOI: 10.26508/lsa.202403091.


Lysophosphatidic acid improves development of porcine somatic cell nuclear transfer embryos.

Sun L, Lin T, Lee J, Kim S, Bai Y, Jin D J Anim Sci Technol. 2024; 66(4):726-739.

PMID: 39165747 PMC: 11331365. DOI: 10.5187/jast.2024.e68.


Loss of KANSL3 leads to defective inner cell mass and early embryonic lethality.

Chander A, Mager J Mol Reprod Dev. 2024; 91(5):e23760.

PMID: 38769918 PMC: 11244731. DOI: 10.1002/mrd.23760.


Single-Cell RNA Sequencing Reveals Differences in Chromatin Remodeling and Energy Metabolism among In Vivo-Developed, In Vitro-Fertilized, and Parthenogenetically Activated Embryos from the Oocyte to 8-Cell Stages in Pigs.

Fan J, Liu C, Zhao Y, Xu Q, Yin Z, Liu Z Animals (Basel). 2024; 14(3).

PMID: 38338108 PMC: 10854501. DOI: 10.3390/ani14030465.


Endogenous retroviruses shape pluripotency specification in mouse embryos.

de la Rosa S, Del Mar Rigual M, Vargiu P, Ortega S, Djouder N Sci Adv. 2024; 10(4):eadk9394.

PMID: 38266080 PMC: 10807815. DOI: 10.1126/sciadv.adk9394.


References
1.
Kamjoo M, Brison D, Kimber S . Apoptosis in the preimplantation mouse embryo: effect of strain difference and in vitro culture. Mol Reprod Dev. 2002; 61(1):67-77. DOI: 10.1002/mrd.1132. View

2.
Nishimoto M, Fukushima A, Okuda A, Muramatsu M . The gene for the embryonic stem cell coactivator UTF1 carries a regulatory element which selectively interacts with a complex composed of Oct-3/4 and Sox-2. Mol Cell Biol. 1999; 19(8):5453-65. PMC: 84387. DOI: 10.1128/MCB.19.8.5453. View

3.
Hardy K . Cell death in the mammalian blastocyst. Mol Hum Reprod. 1997; 3(10):919-25. DOI: 10.1093/molehr/3.10.919. View

4.
Feldman B, Poueymirou W, Papaioannou V, DeChiara T, Goldfarb M . Requirement of FGF-4 for postimplantation mouse development. Science. 1995; 267(5195):246-9. DOI: 10.1126/science.7809630. View

5.
Ambrosetti D, Basilico C, Dailey L . Synergistic activation of the fibroblast growth factor 4 enhancer by Sox2 and Oct-3 depends on protein-protein interactions facilitated by a specific spatial arrangement of factor binding sites. Mol Cell Biol. 1997; 17(11):6321-9. PMC: 232483. DOI: 10.1128/MCB.17.11.6321. View